Evidence that CFTR mutations have an effect on gut microbiota are increasing in humans and in CF mice [13,14], although it is unclear how this gut-lung dysbiosis is influenced by Pseudomonas aeruginosa chronic infection. The gene discussed is CFTR; the disease is cystic fibrosis.